Reardon Andrew sold LGND
May 9, 2024 · Form 4 insider transaction
Reardon Andrew sold 10,000 shares of Ligand Pharmaceuticals Incorporated at $83.04 per share, a transaction worth $830.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$83.04
Total value
$830.4K
InsiderReardon Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 9, 2024
Filing dateMay 13, 2024
Shares owned after22,205
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.27. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.